MCID: CHC001
MIFTS: 56

Chickenpox malady

Categories: Infectious diseases, Skin diseases

Aliases & Classifications for Chickenpox

About this section

Aliases & Descriptions for Chickenpox:

Name: Chickenpox 10 12 36 35 2 65
 
Varicella 10 47

Classifications:



External Ids:

Disease Ontology10 DOID:8659
ICD1027 B01, B01.9, B01.8
ICD9CM29 052
MeSH36 D002644
NCIt42 C97132
UMLS65 C0008049

Summaries for Chickenpox

About this section
MedlinePlus:35 Chickenpox is an infection caused by the varicella-zoster virus. most cases are in children under age 15, but older children and adults can get it. it spreads very easily from one person to another. the classic symptom of chickenpox is an uncomfortable, itchy rash. the rash turns into fluid-filled blisters and eventually into scabs. it usually shows up on the face, chest, and back and then spreads to the rest of the body. other symptoms include fever headache tiredness loss of appetite chickenpox is usually mild and lasts 5 to 10 days. calamine lotions and oatmeal baths can help with itching. acetaminophen can treat the fever. do not use aspirin for chickenpox; that combination can cause reye syndrome. chickenpox can sometimes cause serious problems. adults, babies, teenagers, pregnant women, and those with weak immune systems tend to get sicker from it. they may need to take antiviral medicines. once you catch chickenpox, the virus usually stays in your body. you probably will not get chickenpox again, but the virus can cause shingles in adults. a chickenpox vaccine can help prevent most cases of chickenpox, or make it less severe if you do get it. centers for disease control and prevention

MalaCards based summary: Chickenpox, also known as varicella, is related to purpura and optic neuritis, and has symptoms including anorexia, myalgia and nausea. An important gene associated with Chickenpox is GYPC (Glycophorin C (Gerbich Blood Group)), and among its related pathways are A-beta Pathways: Uptake and Degradation and Malaria. The drugs acyclovir and acyclovir sodium have been mentioned in the context of this disorder. Affiliated tissues include skin, skin and liver, and related mouse phenotypes are renal/urinary system and endocrine/exocrine gland.

Disease Ontology:10 A viral infectious disease that results in infection located in skin, has material basis in Human herpesvirus 3, which is transmitted by direct contact with secretions from the rash, or transmitted by droplet spread of respiratory secretions. The infection has symptom anorexia, has symptom myalgia, has symptom nausea, has symptom fever, has symptom headache, has symptom sore throat, and has symptom blisters.

Wikipedia:68 Chickenpox, also known as varicella, is a highly contagious disease caused by the initial infection with... more...

Related Diseases for Chickenpox

About this section

Diseases related to Chickenpox via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 323)
idRelated DiseaseScoreTop Affiliating Genes
1purpura30.9CD40LG, CD79A
2optic neuritis30.4CD4, CD79A
3secondary syphilis30.1CD4, CD40LG
4monkeypox29.8CD4, CD8A
5congenital varicella syndrome11.3
6herpes zoster10.9
7absence of fingerprints congenital milia10.8ACTC1, MUC1
8benign mesothelioma10.8ACTC1, MUC1
9polymyositis10.8ACTC1, MUC1
10ovarian mucinous cystadenocarcinoma10.8ACTC1, MUC1
11pulmonary immaturity10.8ACTC1, MUC1
12epidermal appendage tumor10.7ACTC1, MUC1
13struma ovarii10.7ACTC1, MUC1
14kidney rhabdoid cancer10.7ACTC1, MUC1
15oral cavity cancer10.6CD4, CD40LG
16hymenolepiasis10.6CD4, CD40LG
17sacral spinal canal and spinal cord meningioma10.6CD4, CD40LG
18scleritis10.6CD4, CD40LG
19lacrimal duct obstruction10.6CD4, CD40LG
20mobitz type ii atrioventricular block10.6CD4, CD40LG
21facial hemiatrophy10.6CD4, CD40LG
22dressler's syndrome10.6CD79A, MUC1
23amenorrhea10.6CD4, CD40LG
24neurofibromatosis10.6CD4, GYPC
25melanoma10.5ACTC1, MUC1
26typhus10.5CD40LG, CD79A
27pulmonary edema10.5CD40LG, CD79A
28congenital hypogammaglobulinemia10.5CD40LG, CD79A
29calabro syndrome10.5CD40LG, CD79A
30gamma heavy chain disease10.5CD40LG, CD79A
31exanthema subitum10.5CD40LG, CD79A
32osteomalacia10.5CD40LG, CD79A
33epidermolysis bullosa simplex10.5CD40LG, CD79A
34proliferative glomerulonephritis10.5CD40LG, CD79A
35cryopyrin-associated periodic syndrome10.5CD40LG, CD79A
36acute salpingitis10.5CD40LG, CD79A
37beriberi10.5CD40LG, CD79A
38cystitis10.5CD40LG, CD79A
39choroid plexus meningioma10.5CD40LG, CD79A
40immunotactoid glomerulopathy10.5CD40LG, CD79A
41cauda equina syndrome10.5ADA, CD40LG
42alpha chain disease10.5CD40LG, CD79A
43dysgammaglobulinemia10.5CD40LG, CD79A
44generalized atherosclerosis10.5CD40LG, CD79A
45central sleep apnea10.5CD40LG, CD79A
46hypothyroidism due to deficient transcription factors involved in pituitary development or function10.5ACTC1, MUC1
47sialadenitis10.5CD40LG, CD79A
48ureteral lymphoma10.5CD40LG, CD79A
49mixed lacrimal gland cancer10.5CD40LG, CD79A
50somatoform disorder10.5CD40LG, CD79A

Graphical network of the top 20 diseases related to Chickenpox:



Diseases related to chickenpox

Symptoms for Chickenpox

About this section

Symptoms:

 10 (show all 7)
  • anorexia
  • myalgia
  • nausea
  • fever
  • headache
  • sore throat
  • blisters

UMLS symptoms related to Chickenpox:


pruritus, exanthema

Drugs & Therapeutics for Chickenpox

About this section

Drugs for Chickenpox (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 94)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
BudesonideapprovedPhase 438151333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide Inhalation
Budesonide MMX
Budesonide Nasal
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
 
Horacort
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort FLEXHALER
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Uceris
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
2AntibodiesPhase 4, Phase 2, Phase 3, Phase 14477
3ImmunoglobulinsPhase 4, Phase 2, Phase 3, Phase 14477
4Immunologic FactorsPhase 4, Phase 3, Phase 2, Phase 118483
5VaccinesPhase 4, Phase 3, Phase 2, Phase 16085
6AcyclovirPhase 4, Phase 3, Phase 2, Phase 1153
7Respiratory System AgentsPhase 43931
8Anti-Infective AgentsPhase 4, Phase 3, Phase 2, Phase 117220
9Heptavalent Pneumococcal Conjugate VaccinePhase 4, Phase 3, Phase 2440
10Pharmaceutical SolutionsPhase 4, Phase 3, Phase 1, Phase 27004
11valacyclovirPhase 4, Phase 3, Phase 2, Phase 1101
12Peripheral Nervous System AgentsPhase 4, Phase 218510
13Antiviral AgentsPhase 4, Phase 3, Phase 2, Phase 18071
14Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 49988
15Anti-Asthmatic AgentsPhase 42796
16Phase 4
17Bronchodilator AgentsPhase 42377
18Anti-Inflammatory AgentsPhase 48478
19HormonesPhase 411748
20glucocorticoidsPhase 43896
21Hormone AntagonistsPhase 410002
22
MelphalanapprovedPhase 3685148-82-34053, 460612
Synonyms:
(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoic acid
(2s)-2-amino-3-(4-[bis(2-chloroethyl)amino]phenyl)propanoic acid
148-82-3
3-(P-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)-L-alanine
3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
3-P-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3-p-(Di(2-chloroethyl)amino)-phenyl-L-alanine
3025 C.B.
3025 c.b
3223-07-2
4-(Bis(2-chloroethyl)amino)-L-phenylalanine
4-14-00-01689 (Beilstein Handbook Reference)
4-[Bis(2-chloroethyl)amino]-L-phenylalanine
4-[Bis-(2-chloroethyl)amino]-L-phenylalanine
AC1LA2OE
ALKERAN (TN)
AY3360000
Alanine Nitrogen Mustard
Alkeran
AmbotzHAA1563
At-290
BIDD:GT0044
BRD-K87827419-001-02-8
BRN 2816456
BSPBio_002407
C13H18Cl2N2O2
CB 3025
CB-3025
CCRIS 374
CHEBI:165415
CHEBI:28876
CHEMBL852
CID460612
D00369
DivK1c_000653
EINECS 205-726-3
HMS2090B09
HMS2091B16
HMS502A15
HSDB 3234
IDI1_000653
KBio1_000653
KBio2_000877
KBio2_003445
KBio2_006013
KBio3_001627
KBioGR_001284
KBioSS_000877
L-3-(P-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(p-(Bis(2-chloroethyl)amino)phenyl)alanine
L-3-(para-(Bis(2-chloroethyl)amino)phenyl)alanine
L-PAM
L-Phenylalanine mustard
L-Sarcolysin
L-Sarcolysine
L-Sarkolysin
LS-15868
LS-865
Levofalan
 
Levofolan
Levopholan
M2011_SIGMA
MELPHALAN (SEE ALSO TRANSGENIC MODEL EVALUATION (MELPHALAN))
MLS001333666
MLS002153368
Melfalan
Melfalano
Melfalano [INN-Spanish]
Melphalan (JP15/USP/INN)
Melphalan Hydrochloride
Melphalan [USAN:INN:BAN:JAN]
Melphalan hydrochloride
Melphalanum
Melphalanum [INN-Latin]
Mephalan
MolPort-003-665-535
NCGC00090757-01
NCGC00090757-02
NCGC00090757-03
NCI-C04853
NINDS_000653
NIOSH/AY3360000
NSC 241286
NSC 8806
NSC-8806
NSC241286
NSC8806
P-Di-(2-chloroethyl)amino-L-phenylalanine
P-L-Sarcolysin
P-N-Bis(2-chloroethyl)amino-L-phenylalanine
Phenylalanine mustard
Phenylalanine nitrogen mustard
Prestwick_1006
RCRA waste no. U150
Rcra waste number U150
SK-15673
SMP2_000174
SMR000058720
SPBio_000287
SPECTRUM1500382
Sarcolysine
Sarkolysin
Spectrum2_000074
Spectrum3_000684
Spectrum4_000882
Spectrum5_001601
Spectrum_000397
TL8001065
TRANSGENIC LEP (MELPHALAN) (SEE ALSO MELPHALAN)
TRANSGENIC MODEL EVALUATION (MELPHALAN)
UNII-Q41OR9510P
melphalan
p-Bis(beta-chloroethyl)aminophenylalanine
p-Di-(2-chloroethyl)amino-L-phenylalanine
p-L-Sarcolysin
p-L-sarcolysine
p-N,N-bis(2-chloroethyl)amino-L-phenylalanine
p-N-Bis(2-chloroethyl)amino-L-phenylalanine
p-N-Di(chloroethyl)aminophenylalanine
p-N-di(chloroethyl)aminophenylala nine
phenylalanine nitrogen mu stard
23
AltretamineapprovedPhase 3, Phase 257645-05-62123
Synonyms:
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylami
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-S-triazine
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
549835_ALDRICH
645-05-6
A 8723
A0567/0026158
A8723_SIGMA
AB00052308
AC-12006
AC1L1CYX
AI3-50852
AKOS001729401
Altretamin
Altretamina
Altretamina [INN-Spanish]
Altretamine (USP/INN)
Altretamine Bellon Brand
Altretamine Chiesi Brand
Altretamine Wassermann Brand
Altretamine [USAN:INN:BAN]
Altretaminum
Altretaminum [INN-Latin]
Altrétamine
BPBio1_001004
BRD-K67043667-001-04-1
BRN 0195058
BSPBio_000912
Bellon Brand of Altretamine
C9H18N6
CAS-654-05-6
CCRIS 5492
CHEBI:24564
CHEMBL1455
CID2123
CPD000058181
ChemDiv2_005185
Chiesi Brand of Altretamine
D006585
D02841
DB00488
DivK1c_000772
EINECS 211-428-4
ENT 50852
EU-0100083
FT-0083576
HEXAMETHYLMELAMINE
HMM
HMS1383L15
HMS1570N14
HMS1922C05
HMS2090G17
HMS2092H16
HMS502G14
HSDB 7559
HTM
HXM
Hemel
Hexalen
Hexalen (TN)
Hexalen, Altretamine
 
Hexamethylmelamine
Hexastat
Hexinawas
I06-0604
IDI1_000772
IDI1_003900
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
KB-913
KBio1_000772
KBio2_001788
KBio2_004356
KBio2_006924
KBio3_002042
KBioGR_001388
KBioSS_001788
LS-1549
Lopac-A-8723
Lopac0_000083
MGI Pharma Brand of Altretamine
MLS000069621
MLS001076123
MolPort-002-111-210
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
NC 195
NCGC00015100-01
NCGC00015100-02
NCGC00015100-03
NCGC00015100-06
NCGC00015100-11
NCGC00021216-03
NCGC00021216-04
NCGC00021216-05
NCGC00021216-06
NCGC00021216-07
NCI-C50259
NCI60_000871
NINDS_000772
NSC 13875
NSC-13875
NSC13875
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Prestwick0_000946
Prestwick1_000946
Prestwick2_000946
Prestwick3_000946
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
S1278_Selleck
SAM002564241
SMR000058181
SPBio_000754
SPBio_003071
SPECTRUM1503065
ST086739
STK749184
Spectrum2_000907
Spectrum3_000951
Spectrum4_001064
Spectrum5_001092
Spectrum_001308
UNII-Q8BIH59O7H
WLN: T6N CN ENJ BN1&1 DN1&1 FN1&1
Wassermann Brand of Altretamine
ZINC00000905
altretamine
no)-s-triazine
24
FamciclovirapprovedPhase 318104227-87-43324
Synonyms:
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester)
104227-87-4
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester)
2-(2-(2-amino-9H-Purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine
9-[4-Acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine
AC-11064
AC1L1FOB
Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester
Anti-Farnesyl Rabbit pAb
BRD-K45033733-001-02-3
BRL 42810
BRL-42810
BSPBio_003489
Bio-0039
C14H19N5O4
CHEBI:4974
CHEMBL880
CID3324
CPD000466375
D00317
DB00426
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine
FCV
Famciclovir
Famciclovir (JAN/USAN/INN)
Famciclovir [USAN:BAN:INN]
Famciclovirum
Famciclovirum [INN-Latin]
Famvir
 
Famvir (TN)
HMS1922L09
HMS2051G22
HMS2090G10
HMS2093K12
I03-0096
IN1338
KBio2_000946
KBio2_003514
KBio2_006082
KBio3_002709
KBioGR_001162
KBioSS_000946
LS-120147
MLS000759505
MLS001424115
MolPort-003-666-602
NCGC00095133-01
NCGC00095133-02
NCGC00095133-03
Oravir
S2467_Selleck
SAM001246732
SMR000466375
SPBio_001202
SPECTRUM1505201
STK623204
Spectrum2_001101
Spectrum3_001675
Spectrum4_000611
Spectrum5_001548
Spectrum_000466
UNII-QIC03ANI02
ZINC01530635
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate
famciclovir
25Immunosuppressive AgentsPhase 3, Phase 210422
26AntimetabolitesPhase 3, Phase 29454
27Alkylating AgentsPhase 33582
28Antineoplastic Agents, AlkylatingPhase 33406
29
LactitolPhase 3, Phase 2320585-86-43871
Synonyms:
4-O-b-D-Galactopyranosyl-D-glucitol, 9CI
E966
Emportal
 
Floralac
Importal
Oponaf
Portolac
30SorivudinePhase 3, Phase 23
31PENTAPhase 3, Phase 2109
322-AminopurinePhase 313
33Liver ExtractsPhase 2, Phase 33572
34
Medroxyprogesterone Acetateapproved, investigationalPhase 213671-58-9
Synonyms:
(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6alpha-methylprogesterone
17-Acetoxy-6α-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone acetate
17α-hydroxy-6α-methylprogesterone acetate
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
6alpha-Methyl-17-acetoxy progesterone
6alpha-Methyl-17alpha-hydroxyprogesterone acetate
6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
6α-Methyl-17-acetoxy progesterone
 
6α-Methyl-17α-hydroxyprogesterone acetate
Depo-provera
Depo-subq Provera
MPA
Makena
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Medroxyprogesterone Acetate
Medroxyprogesterone acetate
Methylacetoxyprogesterone
Metigestrona
Provera
35
TofacitinibapprovedPhase 295477600-75-2
Synonyms:
Tasocitinib
 
Tofacitinib Citrate
Tofacitinibum
Xeljanz
36
Bupivacaineapproved, investigationalPhase 29642180-92-92474
Synonyms:
( inverted exclamation markA)-bupivacaine
(+-)-Bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
(RS)-bupivacaine
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
15233-43-9
2180-92-9
38396-39-3
AB00053674
AC-2096
AC1L1DRE
AC1Q5LX4
AH 250
AKOS001637202
AR-1A0242
Anekain
BPBio1_000298
BRD-A01636364-003-05-2
BSPBio_000270
BSPBio_002607
Bio-0886
Bloqueina
Bucaine
Bucaine (TN)
Bupivacaina
Bupivacaina [INN-Spanish]
Bupivacaine
Bupivacaine (INN)
Bupivacaine Carbonate
Bupivacaine HCL
Bupivacaine HCL KIT
Bupivacaine Hydrochloride
Bupivacaine Monohydrochloride, Monohydrate
Bupivacaine [INN:BAN]
Bupivacainum
Bupivacainum [INN-Latin]
Bupivan
C07529
C18H28N2O
CBupivacaine
CHEBI:3215
CHEMBL1098
CID2474
Carbostesin
D07552
DB00297
DL-Bupivacaine
DUR-843
DepoBupivacaine
 
DivK1c_000758
EINECS 218-553-3
EINECS 253-911-2
Exparel
HMS2090F12
IDI1_000758
KBio1_000758
KBio2_002004
KBio2_004572
KBio2_007140
KBio3_001827
KBioGR_001516
KBioSS_002004
KST-1A4609
L000695
LAC-43
LS-109841
LS-2222
MLS001361336
Marcaina
Marcaine
Marcaine HCL
Marcaine Spinal
MolPort-004-955-820
NCGC00178579-01
NCGC00178579-02
NINDS_000758
NSC119660
Prestwick0_000305
Prestwick1_000305
Prestwick2_000305
Prestwick3_000305
Racemic bupivacaine
SMR000058218
SPBio_001558
SPBio_002489
Sensorcaine
Sensorcaine-MPF
Sensorcaine-MPF Spinal
Spectrum2_001589
Spectrum3_000974
Spectrum4_001098
Spectrum5_001483
Spectrum_001524
Transdur-Bupivacaine
UNII-Y8335394RO
Vivacaine
Win 11318
Win 11318 HCl
bupivacaine
cBupivacaine
dl-1-Butyl-2',6'-pipecoloxylidide
37
LopinavirapprovedPhase 2342192725-17-092727
Synonyms:
(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide
(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide
1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)
192725-17-0
1mui
2o4s
2q5k
2rkf
2rkg
A 157378
A 157378.0
A-157378-0
A-157378.0
AB1
ABT 157378
ABT 378
ABT-378
ABT-378, LOPINAVIR
AC1L3OPJ
AIDS032937
Aluviran
C12871
C37H48N4O5
 
CHEBI:40456
CHEMBL729
CID92727
D01425
DB01601
Kaletra
Koletra
LPV
LS-173766
Lopinavir
Lopinavir (JAN/USAN/INN)
Lopinavir [USAN:INN:BAN]
MolPort-003-848-410
N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide
N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE
NCGC00164576-01
NCGC00164576-02
RS-346
S1380_Selleck
SID124893167
SID144205757
SID50111692
UNII-2494G1JF75
a-157378-0
a-157378.0
38
NeomycinapprovedPhase 1, Phase 2421404-04-28378
Synonyms:
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol
11025-81-3
119-04-0
1393-86-8
1404-04-2
1405-10-3 (sulfate (salt))
4-18-00-07476 (Beilstein Handbook Reference)
72131_FLUKA
AB00443887
AC1L1QVH
Actilin
Actiline
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRN 0101621
BSPBio_000296
C01737
C23H46N6O13
C25H50N6O13
CCRIS 5462
CHEBI:7508
CID8378
Caswell No. 595
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D05140
DB00452
DB00994
EINECS 204-292-2
EINECS 215-766-3
EPA Pesticide Chemical Code 006303
Endomixin
Enterfram
Fradiomycin
Fradiomycin B
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framygen
 
Fraquinol
HMS2089P15
HSDB 3242
LS-96091
LS-96095
MolPort-003-938-736
Myacine
Myacyne
Mycifradin
Myciguent
N1142_SIGMA
NCGC00179612-01
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
NEOMYCIN SULFATE
NMY
Neo-Fradin
Neo-Rx
Neo-fradin
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
Neomycin B Sulfate
Neomycin B sulfate
Neomycin Sulfate
Neomycin Sulphate
Neomycin solution
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
PIMAVECORT
Prestwick3_000158
ST075177
Soframycin
Soframycin Ophthalmic
Soframycine
Theraplusplus Plus
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297
USAF CB-19
VONAMYCIN
Vonamycin powder V
neomycin
39
Ritonavirapproved, investigationalPhase 2850155213-67-5392622
Synonyms:
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
155213-67-5
1hxw
1sh9
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate
538, ABT
A-84538
ABBOTT-84538
ABT 538
ABT 84538
ABT-538
ABT538
AC-733
AC1L94GB
AKOS000280930
Abbott 84538
BIDD:GT0387
BIDD:PXR0023
Bio-0093
C07240
C37H48N6O5S2
CHEBI:45409
CHEMBL163
CID392622
CPD000466395
D00427
D019438
 
DB00503
DRG-0244
FT-0082824
HMS2051B08
HSDB 7160
LS-148860
MLS000759541
MLS001424063
MolPort-000-883-877
N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide
NCGC00159462-02
NSC693184
Norvir
Norvir (TM)
Norvir (TN)
Norvir Sec
RIT
RTV
Ritonavir
Ritonavir (JAN/USAN/INN)
Ritonavir [USAN]
Ritonavir is an inhibitor of HIV protease used to treat HIV infection and AIDS.
Ritonavirum
S1185_Selleck
SAM001246783
SMR000466395
STK634209
ZINC03944422
ritonavir
40
MethotrexateapprovedPhase 214441959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-Methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
Methopterin
Methotextrate
 
Methotrate
Methotrexat
Methotrexate
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metoject
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-Diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Otrexup
Rasuvo
Rheumatrex
Rheumatrex Dose Pack
Trexall
41
Folic Acidapproved, nutraceuticalPhase 2292459-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic Acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
 
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
42
acetic acidapproved, NutraceuticalPhase 28964-19-7176
Synonyms:
ACETATE ion
Acetate
Acetic Acid
Acetic acid, ion(1-)
Azetat
Borofair
CH3-COO(-)
Ethanoat
Ethanoate
Ethanoic acid
 
Ethylate
Ethylic acid
Glacial acetate
Glacial acetic acid
Kyselina octova
MeCO2 anion
Methanecarboxylate
Methanecarboxylic acid
Vinegar
Vinegar acid
Vosol
43Contraceptive AgentsPhase 21706
44Antineoplastic Agents, HormonalPhase 24256
45Contraceptive Agents, MalePhase 2202
46FialuridinePhase 23
47VitaminsPhase 2, Phase 13857
48Vitamin B ComplexPhase 22847
49Trace ElementsPhase 2, Phase 13900
50MicronutrientsPhase 2, Phase 13901

Interventional clinical trials:

(show top 50)    (show all 210)
idNameStatusNCT IDPhase
1Immunogenicity and Safety of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT02173899Phase 4
2Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE VaccineCompletedNCT01815073Phase 4
3Safety of a Second Dose of Biken's Varicella VaccineCompletedNCT00830648Phase 4
4Immunogenicity and Safety Study of 2 Doses of Live Attenuated Varicella VaccineCompletedNCT01817270Phase 4
5Immunogenicity and Safety of Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00126997Phase 4
6Safety and Immunogenicity Study of Live Attenuated Vaccine Against Varicella Without GelatinCompletedNCT01684072Phase 4
7Effective Study of Live Attenuated Varicella Vaccine to Treat Severe Resistant PsoriasisCompletedNCT01356004Phase 4
8The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected ChildrenCompletedNCT01138215Phase 4
9MMR and Varicella Vaccine in Premature InfantsCompletedNCT00156559Phase 4
10Varicella Vaccination With PulmicortCompletedNCT00641446Phase 4
11Concomitant Use of Hepatitis A Vaccine With Measles, Mumps, Rubella and Varicella Vaccine and Pneumococcal 7-Valent Conjugate Vaccine in Healthy 12-Month-Old Children (V251-067)CompletedNCT00312858Phase 4
12Effectiveness Assessment of Vaccinating Schoolchildren Against InfluenzaCompletedNCT01693380Phase 4
13Safety Study of a Refrigerator-Stable Formulation of VARIVAX®CompletedNCT00432731Phase 4
14Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIVCompletedNCT00329251Phase 4
15Zostavax® at Minimum Release Specification Approaching ExpiryCompletedNCT00681031Phase 4
16Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
17ZOSTAVAX™ Safety and Immunogenicity in Korean Adults (V211-034)CompletedNCT01556451Phase 4
18The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses VaccinationRecruitingNCT01866566Phase 4
19Persistence of Varicella Immunity in Hospital Employees Receiving Varicella VaccineRecruitingNCT02026089Phase 4
20Pilot Study to Describe Immune Responses of Healthy Women Following Immunization With Varicella Zoster Virus VaccineRecruitingNCT02514018Phase 4
21Safety and Immunogenicity of a Zoster Vaccine in SLERecruitingNCT02477150Phase 4
22Immune Response to Shingles VaccinationRecruitingNCT02624375Phase 4
23Immune Persistence After Inoculated With One-dose Freeze-Dried Live Attenuated Varicella Vaccine in Children Vaccine in ChildrenActive, not recruitingNCT01982409Phase 4
24T Cell Responses to Varicella Zoster Virus (VZV)Active, not recruitingNCT01911065Phase 4
25Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney TransplantationActive, not recruitingNCT00940940Phase 4
26Study on Effectiveness of 2-dose Live Attenuated Varicella VaccineEnrolling by invitationNCT02146469Phase 4
27The Safety, Immunogenicity and Immune Effect Research of the Varicella Vaccine After the 2nd Dose VaccinationEnrolling by invitationNCT01830283Phase 4
28Immunodeficiency in Cartilage-hair Hypoplasia: Sub-project on Safety of Vaccination Against ChickenpoxEnrolling by invitationNCT02383797Phase 4
29Varicella Zoster Vaccine in Patients With Plaque Psoriasis Treated With Biologic TherapySuspendedNCT02408159Phase 4
30Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella VaccinesTerminatedNCT00138255Phase 4
31Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127023Phase 3
32Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox DiseasesCompletedNCT00127010Phase 3
33Detection and Characterisation of Varicella Zoster Virus From Dermal Lesions of Chickenpox-infected PatientsCompletedNCT00127608Phase 3
34Evaluation Of Valaciclovir In Patients With ChickenpoxCompletedNCT00169416Phase 3
35Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster InfectionCompletedNCT00098046Phase 3
36Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and ChickenpoxCompletedNCT00226499Phase 3
37Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027)CompletedNCT01536405Phase 3
38Immunogenicity & Safety Study of GSK Biologicals' Combined Measles-mumps-rubella-varicella Vaccine 208136CompletedNCT00751348Phase 3
39A Study of BV-araU in the Treatment of Varicella-Zoster Viral Disease (VZV) in HIV-Infected Children Who Have Not Had Success With or Who Cannot Take Other Treatments for VZVCompletedNCT00002358Phase 3
40Comparison of GSK Measles-mumps-rubella-varicella (MMRV) Vaccine Versus PriorixTMCompletedNCT00969436Phase 3
41ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED)CompletedNCT00975507Phase 3
42Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)CompletedNCT00092430Phase 3
43Long-term Follow-up on Immunogenicity & Safety of Measles-Mumps-Rubella-Varicella (MMRV) Combined VaccineCompletedNCT00406211Phase 3
44Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety StudyCompletedNCT00326183Phase 3
45Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy ToddlersCompletedNCT00422292Phase 3
46Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED)CompletedNCT00985153Phase 3
47Shingles Prevention StudyCompletedNCT00007501Phase 3
48Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in ChildrenCompletedNCT00197015Phase 3
49A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014)CompletedNCT00985166Phase 3
50Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)CompletedNCT02062502Phase 3

Search NIH Clinical Center for Chickenpox

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: chickenpox

Genetic Tests for Chickenpox

About this section

Anatomical Context for Chickenpox

About this section

MalaCards organs/tissues related to Chickenpox:

33
Skin, Liver, Breast, Kidney, Brain, Testes, T cells

FMA organs/tissues related to Chickenpox:

16
Skin

Animal Models for Chickenpox or affiliated genes

About this section

MGI Mouse Phenotypes related to Chickenpox:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053678.3ADA, AMHR2, CD36, CD40LG, CD79A
2MP:00053797.7ADA, AMHR2, CD36, CD4, CD40LG, CD8A
3MP:00053976.9ADA, AMHR2, CD36, CD4, CD40LG, CD79A
4MP:00053876.6ADA, AMHR2, CD36, CD4, CD40LG, CD79A

Publications for Chickenpox

About this section

Articles related to Chickenpox:

(show top 50)    (show all 540)
idTitleAuthorsYear
1
Does chickenpox cause childhood stroke? (25758313)
2015
2
Chickenpox complicated by pneumococcal meningitis: A rare coinfection. (25282451)
2014
3
Varicella zoster virus: chickenpox and shingles. (24734838)
2014
4
Acute venous sinus thrombosis after chickenpox infection. (25856952)
2014
5
Natural alteration of antibody titers in a patient with immunoglobulin A deficiency after chickenpox over a 10-year period. (22181566)
2011
6
Retinitis and optic neuritis in a child with chickenpox: case report and review of literature. (20622712)
2010
7
Hemorrhagic Pericarditis in a child with primary varicella infection (chickenpox). (19332925)
2009
8
Exposition to chickenpox of two children with autoinflammatory syndromes under treatment with anakinra. (18172653)
2008
9
Chickenpox in adults - clinical management. (18555533)
2008
10
Chickenpox: very low mortality in France and the USA. (17460860)
2007
11
Occupationally related outbreak of chickenpox in an intensive care unit. (17709931)
2007
12
Acute retinal necrosis complicating chickenpox in a healthy adult--a case report and review of literature. (17984490)
2007
13
Delayed internal ophthalmoplegia and amblyopia following chickenpox. (16691403)
2006
14
Chickenpox in a geriatric patient. (16686890)
2006
15
Should acyclovir be prescribed for immunocompetent children presenting with chickenpox? (15908639)
2005
16
Delayed disseminated Staphylococcus aureus infection following chickenpox. (15151591)
2004
17
Managing shingles and postherpetic neuralgia. Reactivation of the chickenpox virus causes severe pain and rash in older adults. (15153382)
2004
18
A household study of chickenpox in Guinea-Bissau: intensity of exposure is a determinant of severity. (12423611)
2002
19
Chickenpox. (12603904)
2002
20
Deaths from chickenpox. Healthcare workers should not be forgotten. (11887882)
2002
21
The magnitude of variation in temperature within a year has an effect on the seasonal variations of chickenpox incidence in Japan. (11349977)
2001
22
Serotesting versus presumptive varicella vaccination of adolescents with a negative or uncertain history of chickenpox. (11137902)
2001
23
Cost effectiveness of vaccination strategies in adults without a history of chickenpox. (10924649)
2000
24
Managing exposure to chickenpox during pregnancy. New program. (9585843)
1998
25
Hemolytic anemia associated with cold agglutinin during chickenpox and a review of the literature. (9544167)
1998
26
Molecular biology of varicella-zoster virus. A review prepared for the UK Advisory Group on Chickenpox. (9514102)
1998
27
Acute childhood hemiplegia associated with chickenpox. (9568925)
1998
28
A boy with chickenpox whose fingers peeled. (9635952)
1998
29
Chickenpox immunisation in New Zealand. (9734530)
1998
30
Licensed preparations against hepatitis A and chickenpox: vaccine update--Part 2. (9051961)
1996
31
Surgical implications of necrotizing fasciitis in children with chickenpox. (8863250)
1996
32
The protective effect of immunologic boosting against zoster: an analysis in leukemic children who were vaccinated against chickenpox. (8568309)
1996
33
Acyclovir in chickenpox. (8660091)
1996
34
Acyclovir for childhood chickenpox. Cost is unjustified. (7833700)
1995
35
Chickenpox: an error in diagnosis by Hermann Boerhaave? (11616372)
1995
36
Immunisation against chickenpox. (7827547)
1995
37
Anti-epileptic therapy and fatal chickenpox. (8290426)
1993
38
Chickenpox in pregnancy. Pneumonitis more severe. (8518662)
1993
39
Chickenpox stroke in an adult. (8414047)
1993
40
Purpura fulminans due to protein S deficiency following chickenpox. (1386247)
1992
41
Low antibody avidity in elderly chickenpox patients. (1321222)
1992
42
Subconjunctival hemorrhage in chickenpox. (2041675)
1991
43
Orchitis in chickenpox. (2282240)
1990
44
Chickenpox pneumonia: an association with pregnancy. (2330558)
1990
45
Chickenpox: where do we stand with treatment? (2319406)
1990
46
Transmission of chickenpox in a school setting prior to the observed exanthem. (2556025)
1989
47
Should children in renal failure be immunised against chickenpox before receiving a renal transplant. (2642094)
1989
48
Antiviral treatment in chickenpox and herpes zoster. (3339143)
1988
49
Treatment and prognosis of chickenpox in adult renal transplant recipients on cyclosporin. (3122120)
1987
50
Infantile herpes zoster ophthalmicus and acute hemiparesis following intrauterine chickenpox. (3498130)
1987

Variations for Chickenpox

About this section

Expression for genes affiliated with Chickenpox

About this section
Search GEO for disease gene expression data for Chickenpox.

Pathways for genes affiliated with Chickenpox

About this section

GO Terms for genes affiliated with Chickenpox

About this section

Cellular components related to Chickenpox according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1membraneGO:00160208.5ACTC1, ADA, AMHR2, CD79A, GYPC

Biological processes related to Chickenpox according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1positive regulation of T cell activationGO:00508709.8ADA, CD4
2T cell activationGO:00421109.2CD4, CD8A
3positive regulation of calcium-mediated signalingGO:00508508.8ADA, CD4, CD8A

Molecular functions related to Chickenpox according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1coreceptor activityGO:00150269.2CD4, CD8A

Sources for Chickenpox

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet